TrialAmerican heart journal2014

Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: rationale and design of the Insulin Resistance Intervention after Stroke Trial.

Catherine M Viscoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.